Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
5.84M
-
Shares change
-
+123K
-
Total reported value, excl. options
-
$1.81M
-
Value change
-
-$47.8K
-
Put/Call ratio
-
0.73
-
Number of buys
-
15
-
Number of sells
-
-16
-
Price
-
$0.31
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q1 2025
49 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q1 2025.
Co-Diagnostics, Inc. - Common Stock (CODX) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.84M shares
of 38.5M outstanding shares and own 15.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.78M shares), Private Advisory Group LLC (1.18M shares), RENAISSANCE TECHNOLOGIES LLC (550K shares), BlackRock, Inc. (503K shares), GEODE CAPITAL MANAGEMENT, LLC (342K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (273K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (213K shares), CITADEL ADVISORS LLC (189K shares), Bank of New York Mellon Corp (137K shares), and Kestra Advisory Services, LLC (125K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.